News

The specialty pharmaceutical company develops, manufactures and markets a range of pharmaceutical products. Valeant chairman and CEO Michael Pearson said the company had a strong Canadian presence always

The study of the IL-4R alpha inhibitor demonstrated 87% reduction in risk of asthma exacerbations in moderate-to-severe asthma patients with elevated eosinophils. Trial lead investigator and the University

The company has planned to shut down the facility as part of a business transformation. The jobs are expected to be axed around the end of 2014 or

The vaccine, if successful, could potentially allow for manufacturing efficiencies that transform to greater access to the vaccine by the global population. Liquidia CEO Neal Fowler said, "Our

BSC doubled the capacity at the Pharmacenter at the Poland site by investing around PLN18m (€4.3m) in the construction of a new production plant and warehouse. The new

Aradigm finished Phase 2b trials in BE patients with Pulmaquin and Lipoquin while the agreement will focus on advancing the candidate into Phase III trials in BE. Grifols

The benchtop centrifuge has the flexibility to adapt to evolve clinical and research needs including clinical chemistry, cell culture, microbiology and hematology. The small benchtop centrifuge is designed

The Study Of Diabetic Nephropathy with Atrasentan (SONAR) will assess the effects of atrasentan upon addition to standard of care on progression of kidney disease in patients with

The company announced that such results cannot be reached with the mercury amalgam lamps, which are effective only for sanitation till 4 logs of various vials, cups etc.